Bridgeway Capital Management’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-110
| Closed | -$2.97K | – | 1336 |
|
|
2024
Q3 | $2.97K | Sell |
110
-779
| -88% | -$21K | ﹤0.01% | 1253 |
|
|
2024
Q2 | $33.1K | Sell |
889
-200
| -18% | -$7.45K | ﹤0.01% | 1245 |
|
|
2024
Q1 | $51.3K | Hold |
1,089
| – | – | ﹤0.01% | 1264 |
|
|
2023
Q4 | $47.9K | Hold |
1,089
| – | – | ﹤0.01% | 1316 |
|
|
2023
Q3 | $49.6K | Hold |
1,089
| – | – | ﹤0.01% | 1306 |
|
|
2023
Q2 | $73K | Hold |
1,089
| – | – | ﹤0.01% | 1298 |
|
|
2023
Q1 | $46.8K | Sell |
1,089
-421
| -28% | -$18.1K | ﹤0.01% | 1316 |
|
|
2022
Q4 | $47.1K | Hold |
1,510
| – | – | ﹤0.01% | 1304 |
|
|
2022
Q3 | $88K | Hold |
1,510
| – | – | ﹤0.01% | 1298 |
|
|
2022
Q2 | $118K | Sell |
1,510
-100
| -6% | -$7.82K | ﹤0.01% | 1197 |
|
|
2022
Q1 | $171K | Sell |
1,610
-550
| -25% | -$58.4K | ﹤0.01% | 1195 |
|
|
2021
Q4 | $199K | Sell |
2,160
-200
| -8% | -$18.4K | ﹤0.01% | 1164 |
|
|
2021
Q3 | $477K | Sell |
2,360
-100
| -4% | -$20.2K | 0.01% | 1046 |
|
|
2021
Q2 | $529K | Sell |
2,460
-250
| -9% | -$53.8K | 0.01% | 1051 |
|
|
2021
Q1 | $615K | Buy |
2,710
+1,600
| +144% | +$363K | 0.01% | 1042 |
|
|
2020
Q4 | $199K | Buy |
+1,110
| New | +$199K | ﹤0.01% | 1210 |
|